De-escalation of oral P2Y12 inhibitors guided by platelet function testing in ACS patients undergoing PCI: impact of diabetes mellitus

被引：0
|
作者：
Capranzano, Piera [1 ]
Angiolillo, Dominick J. [2 ]
机构：
[1] Univ Catania, Div Cardiol, CAST Policlin Hosp, Via S Sofia 78, I-95123 Catania, Italy
[2] Univ Florida, Coll Med, Div Cardiol, Jacksonville, FL USA
来源：
EUROINTERVENTION | 2019年 / 15卷 / 06期
关键词：
ACUTE CORONARY SYNDROME; TROPICAL-ACS; ANTIPLATELET TREATMENT; FUNCTION PROFILES; ARTERY-DISEASE; CLOPIDOGREL; OUTCOMES; THERAPY; INTERVENTION; GUIDELINES;
D O I：
10.4244/EIJV15I6A89
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E486 / E489
页数：4
相关论文
共 50 条
  • [31] Platelet P2Y12 receptor signaling in patients with diabetes mellitus: an in vitro pharmacodynamic study
    Ueno, M.
    Ferreiro, J. L.
    Dharmashankar, K.
    Capodanno, D.
    Alissa, R.
    Desai, B.
    Tomasello, S. D.
    Charlton, R. K.
    Bass, T. A.
    Angiolillo, D. J.
    EUROPEAN HEART JOURNAL, 2010, 31 : 173 - 174
  • [32] Predictors of In-Hospital De-Escalation of P2Y12 Inhibitors to Clopidogrel in Patients With Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention
    Williams, Michael U.
    Lang, William R.
    Wark, Tyler
    Ovide, Gerry
    Mitsuyama, Rei
    Kadiyala, Vishnu
    Long, Sokunvichet
    Heinl, Robert E.
    Kah, Mustapha Ousman
    Sharma, Esseim
    Hyder, Omar N.
    Bavishi, Chirag
    Kennedy, Kevin F.
    Aronow, Herbert
    Abbott, J. Dawn
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2022, 42 : 155 - 159
  • [33] Impact of P2Y12 Inhibitory Effects Induced by Clopidogrel on Platelet Procoagulant Activity in Type 2 Diabetes Mellitus Patients
    Angiolillo, Dominick J.
    Capranzano, Piera
    Desai, Bhaloo
    Shoemaker, Steven B.
    Charlton, Ronald
    Zenni, Martin M.
    Guzman, Luis A.
    Bass, Theodore A.
    THROMBOSIS RESEARCH, 2009, 124 (03) : 318 - 322
  • [34] PLATELET FUNCTION P2Y12 TESTING USE IN ASSESSING THE RISK FOR HEMORRHAGE IN PATIENTS ON CLOPIDOGREL
    Taylor, Olivia
    Wang, Shan
    Liu, Kui
    Daggubati, Ramesh
    Akerman, Meredith
    CRITICAL CARE MEDICINE, 2020, 48
  • [35] Timing, Selection, Modulation, and Duration of P2Y12 Inhibitors for Patients With Acute Coronary Syndromes Undergoing PCI
    Capodanno, Davide
    Angiolillo, Dominick J.
    JACC-CARDIOVASCULAR INTERVENTIONS, 2023, 16 (01) : 1 - 18
  • [36] Perioperative management of P2Y12 inhibitors in patients undergoing cardiac surgery within 1 year of PCI
    Cao, Davide
    Swain, Julie A.
    Sartori, Samantha
    Nardin, Matteo
    Zhang, Zhongjie
    Roumeliotis, Anastasios
    Nicolas, Johny
    Chiarito, Mauro
    Chandiramani, Rishi
    Pivato, Carlo A.
    Spirito, Alessandro
    Giustino, Gennaro
    Stefanini, Giulio G.
    Dangas, George D.
    Baber, Usman
    Bhatt, Deepak L.
    Adams, David H.
    Sharma, Samin K.
    Kini, Annapoorna S.
    Mehran, Roxana
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2022, 8 (08) : 796 - 805
  • [37] Increased Platelet Size and Elevated P2Y12 mRNA Expression Levels in Patients With Diabetes Mellitus
    Nishikawa, Masako
    Nagura, Yutaka
    Okazaki, Hitoshi
    Kurano, Makoto
    Yatomi, Yutaka
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2025, 47 (01) : 189 - 192
  • [38] Gender-based differences in platelet function and platelet reactivity to P2Y12 inhibitors
    Ranucci, Marco
    Aloisio, Tommaso
    Di Dedda, Umberto
    Menicanti, Lorenzo
    de Vincentiis, Carlo
    Baryshnikova, Ekaterina
    PLOS ONE, 2019, 14 (11):
  • [39] Antiplatelet Therapy n ACS Patients: Comparing Appropriate P2Y12 Inhibition by Clopidogrel to the Use of New P2Y12 Inhibitors
    Ristorto, Jessica
    Messas, Nathan
    Marchandot, Benjamin
    Kibler, Marion
    Hess, Sebastien
    Meyer, Nicolas
    Schaeffer, Michael
    Tuzin, Nicolas
    Ohlmann, Patrick
    Jesel, Laurence
    Morel, Olivier
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2018, 25 (08) : 674 - 689
  • [40] Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study
    Oliva, Angelo
    Cao, Davide
    Shneyderman, Mark
    Gitto, Mauro
    Di Muro, Francesca Maria
    Sartori, Samantha
    Vogel, Birgit
    Bay, Benjamin
    Nicolas, Johny
    Johnson, James
    Sweeny, Joseph
    Serrao, Gregory
    Moreno, Pedro
    Kini, Annapoorna
    Dangas, George
    Sharma, Samin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (18) : B27 - B28
12345